Mutagenic nucleoside analogues for use as antivirals by error catastrophe

被引:0
|
作者
Too, K [1 ]
Brown, DM [1 ]
Loakes, D [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
来源
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Error catastrophe using mutagenic nucleoside analogues can be employed as a strategy for inhibiting viral replication. Such ribonucleoside analogues would have to possess a degenerate base and be incorporated into the viral genome. To this end, a library of N-6-hydroxy, methoxy or amino adenosine analogues was prepared. These analogues have significantly altered tautomeric constants (K-T approximate to 10-100) when compared to the native nucleotides (K-T approximate to 10(4)-10(6)). Minor tautomers have been implicated in giving rise to mutations and a modest increase in the viral mutation rate could potentially result in reduced viability of progeny viruses, thereby inhibiting viral replication.
引用
收藏
页码:315 / 318
页数:4
相关论文
共 50 条
  • [31] Mechanisms of ribavirin early antiviral effect in chronic hepatitis C: Is it related to ribavirin mutagenic properties inducing error catastrophe?
    Pawlotsky, JM
    Brillet, R
    Hezode, C
    Dhumeaux, D
    HEPATOLOGY, 2003, 38 (04) : 730A - 730A
  • [32] Lethal mutagenesis of HIV with mutagenic nucleoside analogs
    Loeb, LA
    Essigmann, JM
    Kazazi, F
    Zhang, J
    Rose, KD
    Mullins, JI
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) : 1492 - 1497
  • [33] ERROR CATASTROPHE HYPOTHESIS AND AGING
    GOEL, NS
    YCAS, M
    JOURNAL OF MATHEMATICAL BIOLOGY, 1976, 3 (02) : 121 - 147
  • [34] Avoiding a catastrophe of human error
    Hooke, WH
    BULLETIN OF THE AMERICAN METEOROLOGICAL SOCIETY, 2005, 86 (02) : 156 - 158
  • [35] Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals
    Krecmerova, Marcela
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (10) : 818 - 833
  • [36] Error catastrophe and antiviral strategy
    Eigen, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13374 - 13376
  • [37] CURRENT STATUS OF NUCLEOSIDE ANTIVIRALS IN CHRONIC HEPATITIS B
    Duong, Anhtung
    Mousa, Shaker A.
    DRUGS OF TODAY, 2009, 45 (10) : 751 - 761
  • [38] Use of Non-Nucleoside Analogues Together with Rifampin in HIV Patients with Tuberculosis
    Villar, J.
    Sanchez, P.
    Gonzalez, A.
    Sorli, L.
    Montero, M. M.
    Guelar, A.
    Sole, E.
    Lopez, J. L.
    Knobel, H.
    HIV CLINICAL TRIALS, 2011, 12 (03): : 171 - 174
  • [39] Correlation between laboratory parameters and use or discontinuation of nucleoside analogues in the MONET trial
    Hill, A.
    van Delft, Y.
    Moecklinghoff, C.
    ANTIVIRAL THERAPY, 2009, 14 (07) : A44 - A45
  • [40] ACYCLIC NUCLEOSIDE AND NUCLEOTIDE ANALOGS - A NEW CLASS OF ANTIVIRALS
    HOLY, A
    FARMACO, 1991, 46 (01): : 141 - 146